- GE Healthcare IPO this year ‘looks unlikely’ after Danaher deal, CEO Culp saysCNBC
- GE to sell BioPharma business to Danaher for $21.4BFox Business
- GE to Sell Its Biotech Business to Danaher for $21 BillionThe Wall Street Journal
- GE shares surge 13% after Danaher agrees to buy biopharma business for $21.4 billionCNBC
- GE sells BioPharma business to CEO’s former company for $21.4 billionCNN
- View full coverage on Google News